Learn practical strategies for building a multidisciplinary myositis center, improving patient care, and fostering research collaboration.
π Register here: https://t.co/GPzLn7jVlJ
#Myositis#MCTC#Rheumatology
IIMagine what's next in myositis care. Join me, Dr. Lisa Christopher-Stine (@DrLisaCS) & Dr. Julie Paik (@JuliePaikMD) at #ACR2026 on 11/10 at 5:30 PM EST (live) or 11/18 at 7 PM EST (virtual) with
@PeerView: https://t.co/eYFXpUwolg
University of Pittsburgh/UPMC: 1-year ACGME-recognized Myositis Fellowship starts July 2027. Rheumatology, Neurology, Pulmonary & Dermatology trained applicants worldwide. Visa assistance. Apply by Dec 2026 for 2027β28; interviews Nov/Dec 2026. Info: [email protected]#Myositis
Myositis docs and researchers - Join MCTC event at ACR 2026 ! Looking forward to excellent panel discussions on @valorforDM , Alkivia, Nerandomilast, Cellular therapies in myositis, and Peds Rheum during MCTC meeting at ACR.
π’ Join us at MCTC at ACR Convergence 2026!
π November 9 | 5β7 PM EST
π Hyatt Regency, Orlando
Explore ongoing research, clinical trials, and collaborations in idiopathic inflammatory myopathies.
π https://t.co/IXdKGapigU
#ACR26#Myositis#MCTC
Exciting initiative by @MyositisIndia!
Enigmatic Case Presentation Competition 2026 β Part I
with 14 shortlisted presenters.
π Oct 18 | 5:30 PM IST | Virtual
Join rheumatologists, fellows & trainees!
Register: https://t.co/vhwWsroUKr
#Rheumatology#Myositis#MyositisIndia
Living with myositis? Join global research from your phone π
My PACER Study (Univ of Pittsburgh) is 100% remote. No clinic visits, just a short questionnaire every 6 months via the MyCap app.
Open to adults with myositis - https://t.co/C2JuFPVayu
#Myositis#RareDisease
Exciting initiative by @MyositisIndia!
Enigmatic Case Presentation Competition 2026 β Part I
with 14 shortlisted presenters.
π Oct 18 | 5:30 PM IST | Virtual
Join rheumatologists, fellows & trainees!
Register: https://t.co/vhwWsroUKr
#Rheumatology#Myositis#MyositisIndia
Delighted to announce that Dr. Zechen Ma has joined UPMCβs Myositis Fellowship Program for 2026-2027! With training from McMaster, Alberta, and Toronto, she brings a strong clinical foundation. We look forward to supporting her in advancing myositis care.
#Myositis#Rheumatology https://t.co/OQweFF5E1I
Delighted to announce that Dr. Zechen Ma has joined UPMCβs Myositis Fellowship Program for 2026-2027! With training from McMaster, Alberta, and Toronto, she brings a strong clinical foundation. We look forward to supporting her in advancing myositis care.
#Myositis#Rheumatology https://t.co/OQweFF5E1I
Inviting all MCTC members to join the 2026 General Body Meeting and discover the latest updates and upcoming developments in myositis clinical trials and research.
Looking forward to MCTC CAR-T webinar @MctcMyositis
Join us for βLatest Advances in CAR T-Cell Therapy for Inflammatory Myopathies,β featuring Dr. Vikas Majithia and moderated by Dr. Mathilde Bandeira.
π September 25, 2026
β° 10 AM ET
π https://t.co/MDsFhg1gP3
#Myositis#CAR
π¨#Myositis Breaking News: FDA approves the 1st-ever oral targeted therapy for #Dermatomyositis β brepocitinib (Lisraya), a JAK1/TYK2 inhibitor. With Brepo + IVIG now approved, itβs time to reduce our reliance on long-term steroids. Big step forward ! π https://t.co/B842tWaX9F
Novel tx for Myositis : After IVIG (ProDERM by Octapharma) & Brepocitinib (Valor by Priovant) in DM, for the first time we have highly positive phase 3 trial for IMNM & DM. Efgartogimod SQ (anti-FcRN) showed significant improvement in IMNM & DM vs. PBO.
https://t.co/LbiCC7YBzf
MCTC Webinar: CAR-T Cell Therapy Advances in Inflammatory Myopathies
Join Dr. Vikas Majithia (Mayo Clinic Jacksonville) one with most experience in CAR-T, moderated by Dr. Matilde Bandeira, for the research updates.
π Sept. 25, 2026 | 10 AM EST
#CART#Myositis#MCTC#Research https://t.co/heUiKAEkfC
π§ Living with myositis?
You can help advance research-right from your phone, anywhere in the world
Join My PACER Registry, a global myositis study by the University of Pittsburgh.
π https://t.co/RFCn9FQ1Mh
#Myositis#Dermatomyositis#Polymyositis#MyositisResearch#RareDisease
Myositis India invites MD/DNB/DM/DrNB trainees to participate in the Enigmatic Case Presentation Competition 2026. Submit a 300-word abstract on an interesting myositis-related case. Winners will be felicitated at IRACON 2026. Deadline: 15 Jul 2026. #MyositisIndia#IRACON2026
Medical trainees, present your interesting myositis case before the Stalwarts of Rheumatology!
Myositis India invites submissions for the 2026 Enigmatic Case Presentation Competition.
Open to MD, DNB, DM & DrNB trainees.
Deadline: 15-07-2026
Email: [email protected]
#PatientStories
Meet Mr Prashant Varma, our braveheart volunteer, diagnosed with myositis in 2020 after visiting multiple doctors. For him, finally getting a diagnosis was bittersweet.
Register: https://t.co/PuX7yajzGN
Donate: https://t.co/NAdXSIeiHu
#MyositisIndia@docrota
This Myositis Awareness Month, we share the inspiring journey of our ambassador @Samanthaprabhu2 , who faced Myositis with courage and continues to inspire patients, caregivers, & supporters.
@Myositis_India is here for you at every step.
Donate: https://t.co/NAdXSIeiHu
@docrota
Join Myositis India for the Physician Webinar on βInterferons in IIMβ on 31 May 2026 | 8 PM IST.
Featuring Dr. Akira Yoshida & Dr. Rudrarpan Chatterjee.
Register here: https://t.co/wn2Mp8MFYD
#Myositis#Rheumatology#IIM
Understanding Interferons in IIM: from pathogenesis to clinical relevance.
Join Myositis India for a webinar on interferon signatures, their role in IIM, and what it means for clinical practice.
π 31 May 2026
β° 8 PM IST
π Zoom
Scan QR to register.